CCL14 is constitutively expressed in multiple tissues, including the spleen, bone marrow, liver, muscle, and gut . It induces changes in intracellular calcium concentration and enzyme release in monocytes . Upon processing of the N-terminal residues by the uPA-plasmin system, the active form of CCL14 acts as a strong agonist for CCR1, CCR5, and, to a lesser extent, CCR3 . This active form is also a potent inhibitor of HIV entry .
CCL14 causes chemotaxis of different types of leukocytes, which is crucial for immune response . Its ability to chemoattract human monocytes has been demonstrated in functional assays, with effective concentrations ranging from 5.0 to 20.0 ng/ml . The active form of CCL14 is particularly significant in immune regulation and inflammatory responses.
Recombinant human CCL14 is produced in E. coli and is available for research purposes . It is used in various functional assays to study its role in chemotaxis and immune response. The recombinant protein is typically lyophilized and requires reconstitution before use . It is important to handle and store the protein under specific conditions to maintain its stability and activity .